On January 5, 2026, the in-session gains of stocks related to the brain-computer interface concept continued to expand. Biotest, Aerospace Changfeng hit the daily limit, and nearly 20 stocks, including Beiyikang and Sanbo Brain Hospital, also hit the daily limit, while multiple stocks such as Guanhao Biotechnology rose by more than 10%. On the news front, Musk stated that Neuralink plans to initiate large-scale production of brain-computer interface devices in 2026.
